PolyPid Announces Positive FDA Type B Meeting Feedback for D-PLEX₁₀₀ Development Program

FDA Agreed that a Single Pivotal Phase 3 Study is Sufficient for Potential Approval of D-PLEX 100 for the Prevention of Surgical Site Infections in Colorectal Surgery. Enrollment in Phase 3 SHIELD I Trial of D-PLEX 100 in Abdominal Surgery Continues to Advance ; Over 200 Patients Enrolled to